Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Canine Stem Cell Therapy
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Allogeneic Stem Cells, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$174.8 Million by ... Read More
-
CAR T-cell Therapy
... at a CAGR of 22.0% over the analysis period 2024-2030. DLBCL Indication, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.1 Billion by the end of ... Read More
-
Cord Blood Banking Services
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Private Blood Banks, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$79.3 Billion by ... Read More
-
Allogeneic Stem Cells
... at a CAGR of 10.9% over the analysis period 2024-2030. Regenerative Therapy Application, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.6 Billion by the end ... Read More
-
Rat Model
... CAGR of 7.1% over the analysis period 2024-2030. Inbred Rat Model, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the ... Read More
-
Stem Cell Services
... at a CAGR of 9.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market in the U.S. ... Read More
-
Live Cell Imaging
... at a CAGR of 7.5% over the analysis period 2024-2030. Live Cell Imaging Instruments, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Cell Therapy
... CAGR of 14.1% over the analysis period 2024-2030. Allogenic Cell Therapy, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$23.4 Billion by the end of the ... Read More
-
Amyloidosis Treatment
... CAGR of 6.8% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end of the analysis period. ... Read More
-
Stem Cell Manufacturing
... at a CAGR of 7.8% over the analysis period 2024-2030. Culture Media, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.2 Billion by the end of ... Read More
-
Stem Cell Therapy
... at a CAGR of 16.4% over the analysis period 2024-2030. Allogeneic Stem Cell Therapy, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$1.0 Billion by the ... Read More
-
Human Embryonic Stem Cell (hESC) Research
... reach US$1.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and ... Read More
-
Biopreservation
... 8.0% over the analysis period 2024-2030. Biopreservation Media, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Human Organoids
... CAGR of 15.4% over the analysis period 2024-2030. Kidney, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Humanized Mouse and Rat Model
... Million by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Humanized Rat Models, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$13.6 ... Read More
-
Cell Expansion
... CAGR of 14.8% over the analysis period 2024-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the ... Read More
-
Cell Viability Assays
... at a CAGR of 7.1% over the analysis period 2024-2030. Cell Viability Assay Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the ... Read More
-
Exosomes
... 11.3% over the analysis period 2024-2030. Other Disease Indications, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$377.0 Million by the end of the analysis period. ... Read More
-
Stem Cells
... CAGR of 7.4% over the analysis period 2024-2030. Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$17.8 Billion by the end of the ... Read More
-
Primary Cells
... CAGR of 7.1% over the analysis period 2024-2030. Human Primary Cells, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$1.4 Billion by the end of the ... Read More
-
Stem Cell Assays
... at a CAGR of 17.9% over the analysis period 2024-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by the end of ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Orthopedic Cell Therapy Market Size, Share, and Trend Analysis - Global - 2025-2031 - MedCore - Includes: Platlet-Rich Plasma Market and Bone Marrow Aspirate Concentrate Market
... Platelet-Rich Cell Therapy Bone Marrow Cell Therapy Market Insights & Data Coverage Unit Sales & Average Selling Prices Market Size & Growth Trends Procedure Numbers Market Drivers & Limiters Market Forecasts Until 2031 Historical Data ... Read More
Research Assistance
